2008 Scientific Articles

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine 2008.

Batten BC, Sparks RC, Slade BA. “The Clinical Immunization Safety Assessment (CISA: network: conducting clinical research in vaccine safety)”. National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Benson PJ, Jackson LA, Rees TG, Dunn JB. Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine. Human Vaccine 2008;4(3):234–237.

Broder KR, Cohn AC, Schwartz B, Klein JD, Fisher MM, Fishbein DB, Mijalski C, Burstein GR, Vernon-Smiley ME, McCauley MM, Wibbelsman CJ; Working Group on Adolescent Prevention Priorities. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics 2008;121 Suppl 1:S25–34.

CDC. Syncope after vaccination—United States, January 2005–July 2007. MMWR. 2008;57(17):457-460.

Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, Berger T, Flanders WD, Shope R. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003–2004. Clinical Infectious Diseases 2008;46 Suppl 3:S271–293.

Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Event Reporting System, 1995–2005.* Journal of Infectious Diseases 2008;197(S2):S170–S177.

Clayton HA, Cortese MM, Payne DC, Bartlett DL, Zimmerman LA, Williams WG, Wang M, Stockman LJ, Parashar U, Baggs J. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule—United States, February 2006–May 2007. MMWR 2008;57(15):398–401.

Fishbein DB, Broder KR, Markowitz L, Messonnier N. New, and some not-so-new, vaccines for adolescents and diseases they prevent. Pediatrics 2008;121 Suppl 1:S5–14.

France EK, Glanz JM, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly J, Jackson L, Nordin J, Belongia E, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008;121(3):e687–e692.

Gidudu J, Kohl KS, Halperin S, Hammer SJ, Heath PT, Hennig R, Hoet B, Rothstein E, Schuind A, Varrichio F, Walop W. The Brighton Collaboration Local Reactions Working Group for A Local Reaction at or near Injection Site. Vaccine 2008;26(52);6800–6813.

Glanz JM, France EK, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008;121(3):e506–e512.

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar U; Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008; Volume 121:206-1212.

Haber P, Sejvar J, Slade B, Mikaeloff M, DeStefano F. Vaccines and Gillain Barre Syndrome: A literature review, in preparation.

Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2008; 57(28):779.

Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R. Kawasaki disease after vaccination: Reports to the Vaccine Adverse Event Reporting System 1990-2000, in preparation.

Huang WT, Miller ER, Broder KR, Slade BA, Gee J, Kroger A, Markowitz L, Iskander J. “Syncope and related injuries after vaccination.” National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Iskander J, Broder K. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. Expert Review of Vaccines 2008;7(1):75–82.

Iskander J, Gidudu J, Arboleda N, Huang WT. Selected Major Issues in Vaccine Safety. Ann Nestle 2008;66:93-102.

Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ; Vaccine Safety Datalink. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008;121(3):463–469.

LaRussa P, Edwards K, Dekker C, Klein NP, Halsey N, Marchant C, Baxter R, Engler R, Kissner J, Slade B. The Clinical Immunzation Safety Assessment (CISA) initiative, a progress report: 2001-2008, in preparation.

Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta H, Slade B, Ball R, Miller N, Braun M, Markowitz L, Iskander J. Postlicensure safety surveillance for quadrivalent human human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, June 2006 to June 2007, in preparation.

Leung J, Rue A, Lopez A, Ortega-Sanchez IR, Harpaz R, Guris D, Seward JF. Varicella outbreak reporting, response, management, and national surveillance.* Journal of Infectious Diseases M2008;197(S2):S108–S113.

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine 2008 May 5.

McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children < 2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008;26(3):427–429.

Miller ER, Hibbs BF, Slade BA. “Vaccination administration errors reported to the vaccine adverse events reporting system (VAERS).” National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Morgan J, Roper MH, Sperling L, Schieber RA, Heffelfinger JD, Casey CG, Miller JW, Santibanez S, Herwaldt B, Hightower P, Moro PL, Hibbs BF, Levine NH, Chapman LE, Iskander J, Lane JM, Wharton M, Mootrey GT, Swerdlow DL. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January–October 2003. Clinical Infectious Diseases 2008;46 Suppl 3:S242–250.

Nachamkin, I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, Corcoran AT, Iskander JK, Schonberger LB, Chen RT. Anti-Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine-Associated Guillain-Barre Syndrome. Journal of Infectious Diseases 2008;198(2):226-233

Slade B. “Public health genomics trainee experience at CDC: genomics and immunization.” The 5th CDC Public Health Genomics Collaboration Meeting. Atlanta, GA. May 12, 2008.

Slade B. “Clinical Immunization Safety Assessment (CISA) network: activities related to human papillomavirus vaccine (HPV4).” Atlanta, GA. October 22, 2008.

Slade, BA, Gargiullo P, Batten B, Iskander J, CISA, VSD. “Vaccine safety in the era of genomics.” CDC's 10th year anniversary of public health genomics. Atlanta, GA. Jan. 23, 2008.

Sutherland A, Izurieta H, Ball R, Braun MM, Miller ER, Broder KR, Slade BA, Iskander JK, Kroger AT, Markowitz LE, Huang WT. Syncope after vaccination—United States, January 2005–July 2007. MMWR 2008;57(17):457–460.

Swerdlow DL, Roper MH, Morgan J, Schieber RA, Sperling LS, Sniadack MM, Neff L, Miller JW, Curtis CR, Marin ME, Iskander J, Moro P, Hightower P, Levine NH, McCauley M, Heffelfinger J, Damon I, Török TJ, Wharton M, Mast EE, Mootrey GT; Smallpox Vaccine Cardiac Adverse Events Working Group. Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003. Clinical Infectious Diseases 2008;46 Suppl 3:S234–241.

Tatti KM, Slade BA, Patel M, Messonier NR, Jackson T, Kirkland K, Talbot E, Tondella ML. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines. Pediactrics Infectious Disease Journal 2008;27(1):73-74.

Thomas TN, Reef S, Neff L, Sniadack MM, Mootrey GT. A review of the smallpox vaccine adverse events active surveillance system. Clinical Infectious Diseases 2008;46 Suppl 3:S212–220.

Wood Robert A, Berger M, Dreskin SC, Setse R, Engler RJM, Dekker CL, Halsey NA. An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines. Pediatrics 2008;122(3):e771-e777.